ArticleMolecules (Basel, Switzerland)2026
Polysaccharide Hydrogels Doped with MXenes for Possible Biomedical Applications.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
MXenes, a new family of two-dimensional transition-metal carbides and nitrides, have attracted significant interest in biomedicine because of their tunable surface groups and multifunctional properties. Hydrogels, with their three-dimensional polymeric networks rich in water, provide excellent biocompatibility and structural similarity to those of biological tissues. Although synthetic polymer-based MXene hydrogels are well studied, polysaccharide-based systems remain underexplored despite their biodegradability and biomedical relevance. In this work, MXene nanosheets were incorporated into a sodium alginate (ALG)-gellan gum (GG) polymeric blend to develop polysaccharide/MXene hydrogels. Two dehydration approaches, conventional drying and freeze-drying were used to evaluate their influence on the characteristics of the composite, including microstructure, surface roughness, compressive behavior, water states, and thermal stability. Conventionally dried polysaccharide/MXene nanocomposites with 1.0% wt. MXene have reduced the swelling ratio by ~60% and the volume change by 40% compared to polysaccharide blend. Freeze-dried polysaccharide/MXene nanocomposite hydrogels developed a porous, interconnected network, making them promising for applications requiring high surface area, such as adsorption and tissue engineering. In contrast, conventionally dried samples formed compact, smooth structures with improved barrier and mechanical performance. These results demonstrate that the dehydration strategy strongly governs the polymer network architecture, water states, and material functionality, offering pathways to tailor hydrogel modified with MXene for specific biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.